CA-COGNIGY
11.6.2024 13:31:31 CEST | Business Wire | Press release
Cognigy, a global leader in AI-first customer service automation, announced today that it has raised $100 million in Series C funding. The round was led by Eurazeo Growth, with participation from existing investors Insight Partners, DTCP and DN Capital and others. The new funding will accelerate Cognigy’s mission to deliver AI-first customer service at scale.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611735929/en/
Cognigy has raised $100 million in Series C funding, which will accelerate its mission to deliver AI-first customer service at scale. The company was founded in 2016 by (from left to right) Benjamin Mayr, Philipp Heltewig and Sascha Poggemann. More than 1,000 brands worldwide rely on Cognigy’s AI platform to deliver exceptional customer service. (Photo: Business Wire)
Cognigy provides a market-leading enterprise-grade AI platform to build, operate and analyze the advanced AI Agent workforce that many major brands including Lufthansa Group, Virgin Pulse, Frontier Airlines, Bosch, Toyota, TechStyle Fashion Group and Mercedes-Benz rely on today to deliver exceptional customer service. Cognigy’s AI-first approach uses both Conversational and Generative AI to deliver pre-trained AI Agents that resolve high-volume customer requests at scale. This allows enterprise customer service leaders to focus their scarce human agents on high-value conversations. As well as serving end customers, the same AI Agents switch roles to act as Agent Copilots, providing instant and contextual assistance to human agents and automating routine tasks such as call wrap-up.
“Delightful customer service is a top priority for enterprises and is one of the pain points pervading every industry that technology has not been able to solve successfully to date. Cognigy’s enterprise-grade orchestration layer for AI Agents works alongside human agents to deliver a highly effective, personalized service on any channel,” said Raluca Ragab, Managing Director, Head of UK and DACH of Eurazeo Growth.
“We spoke to a large number of Cognigy’s customers as part of our research and, without exception, they all would recommend Cognigy because the platform enables them to reach a very high level of automation (70%+) across millions of conversations with no latency, which is very complex to do. We are proud to support Cognigy’s global growth and mission to revolutionize conversation automation for the enterprise. This investment aligns perfectly with our Eurazeo Growth strategy of supporting European AI champions and scaling them up to become global category leaders,” added Romain Mombert, Director of Eurazeo Growth.
This announcement follows years of triple digit growth for Cognigy, fueled by an increase in market demand across all industries. In the last 12 months, Cognigy has seen explosive growth in the use of its platform, with hundreds of millions of interactions handled on the platform.
“The market opportunity for AI-first customer service is immense,” said Philipp Heltewig, Co-founder and CEO of Cognigy. “Enterprises across all industries are recognizing the critical need for efficient, scalable, and personalized customer interactions. Our platform delivers and manages AI Agents that revolutionize the customer service landscape, providing businesses with the tools to exceed customer expectations and drive loyalty. This funding will enable us to seize this opportunity, expand our global footprint, and continue to innovate our platform to meet the evolving needs of our clients.”
According to Gartner, the Conversational AI market is projected to reach $36 billion in revenue by 2032, up from $8.2 billion in 2023.
In addition to fuelling Cognigy’s global expansion, the new capital round will be directed toward enhancing Cognigy’s research and development efforts in Conversational AI with Generative AI, enabling the creation of more sophisticated and intuitive customer service solutions, and the acceleration of cutting-edge AI-first technologies that deliver concrete ROI.
“We continue to see tremendous potential in Cognigy’s AI-first approach to customer service,” said Teddie Wardi, Managing Director at Insight Partners. “The company’s innovative technology and strong leadership team position Cognigy as a market leader in enterprise customer service automation, as evidenced by top rankings in Gartner and Forrester’s Conversational AI reports. We are excited to continue our support of Cognigy’s vision and growth.”
Customers Speak Out
Over 1,000 brands worldwide rely on Cognigy’s AI platform with millions of transactions processed per day in production.
“AI-first customer service is the future for every large enterprise. Cognigy’s AI Agents deliver instant and personalized service at scale, which has been critical to our operations and is helping millions of our customers every year. We congratulate Cognigy on their funding and look forward to further innovation,” said Nick Allgaier, Product Manager “Digital Assistants” Lufthansa Group.
“Through the use of state-of-the-art AI technology that we have obtained with Cognigy, it is now possible for airports to elevate their communication and interaction with passengers to a new level,” said Alexander Lacker, Product Manager Terminal Processes & Passengers at Munich Airport.
“AI-based Phone and Chatbots can help companies elevate customer service to the next level. Cognigy’s groundbreaking combination of Generative and Conversational AI empowers companies such as ERGO to develop and implement multiple Next-Gen AI Agents for customer service across voice and chat channels, while being flexible, scalable, and compliant,” commented Hanbing Ma, Head of Innovation & Digital Transformation at ERGO.
“We are on a mission to redefine the standards of customer service by leveraging the transformative power of Conversational AI and GenAI. Our collaboration with Cognigy is a testament to our commitment to pioneering solutions that are at the forefront of technology and meet our members’ needs. The integration of Cognigy’s technology into our service framework is a game-changer, setting a new benchmark for excellence in the industry,” said Jack Roberts, Director of GMS Technology & Applications at TechStyleOS.
“Toyota vehicle owners embraced Contact Center AI already before the hype. Why? Because it works. With Cognigy’s AI Agents, we stay ahead and provide real value to customers and car dealerships,” said Peter-Pascal Meik, Manager Innovation & Projects at Toyota.
“With Cognigy’s AI Agents, we help our valued consumers and at the same time are building direct relationships and enhancing our brand experience. Cognigy.AI is flexible enough to cover various use cases while providing a common framework for global scaling and governance,” said Christian Hohmann, Head of New Technologies (AI) & IT-Management at Henkel.
To learn more, visit the Cognigy website at www.cognigy.com.
About Cognigy
Cognigy is revolutionizing the customer service industry by providing the most cutting-edge AI workforce on the market. Its award-winning solution empowers businesses to deliver exceptional customer service that is instant, personalized, in any language, and on any channel. Through the perfect combination of Generative and Conversational AI, Cognigy’s AI Agents are shaping the future of customer service, increasing customer satisfaction, and supporting employees in real-time. Over 1000 brands worldwide trust Cognigy and its vast partner network to create AI customer service agents for their business. Cognigy’s worldwide customer portfolio includes Bosch, Frontier Airlines, Lufthansa Group, Mercedes-Benz, and Toyota.
Follow the company on X (formerly Twitter) @Cognigy and on LinkedIn at https://www.linkedin.com/company/cognigy.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240611735929/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
